Clinical Trial Update: Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating chemoembolisation for patients with non-resectable, non-metastatic hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED